Patent · US Active

Inflammation therapy

US9763894B2 · kind B2 · utility

0Cited by

11References

4Claims

0Family size

Assignees

Virginia Commonwealth University · US
Organix, Inc. · US
TEMPLE UNIVERSITY · US

Inventors

Billy Martin · Richmond, US
Mohamad Imad Damaj · Richmond, US
Martin W. Adler · Dresher, US
Ronald F. Tuma · Philadelphia, US
Ming Zhang · Philadelphia, US
Anu Mahadevan · Westford, US
Raj K. Razdan · Belmont, US

Key dates

Filing date	Dec 5, 2007
Grant date	Sep 19, 2017
Priority date	—
Expiry date	Jul 14, 2032

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61P25/28
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

A method is provided for treating a patient in need of therapy for central nervous system inflammation comprising administering to that patient a therapeutically effective amount of a cannabinoid agonist having efficacy at the CB2 receptor but having substantially no efficacy at the CB1 receptor at that amount.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.